Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
43
BIIB Quote, Financials, Valuation and Earnings
Last price:
$140.99
Seasonality move
:
0.65%
Day range:
$139.87 - $142.18
52-week range:
$128.51 - $238.00
Dividend yield:
0%
P/E ratio:
12.59x
P/S ratio:
2.13x
P/B ratio:
1.23x
Volume:
3.4M
Avg. volume:
1.8M
1-year change:
-36.17%
Market cap:
$20.6B
Revenue:
$9.7B
EPS (TTM):
$11.19
Earnings Data
Next earnings date for BIIB
Apr 24
2025
Most recent earnings per share
$1.83
Missed by $1.53
(Feb 12/2025)
Consensus Estimate
$3.36
(Feb 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BIIB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/24/2025 | Q1 | $2.2B | -- | -- | $3.62 | -- |
| 02/12/2025 | Q4 | $2.4B | $2.5B | $1.83 | $3.36 | -$1.53 |
| 10/30/2024 | Q3 | $2.4B | $2.5B | $2.66 | $3.79 | -$1.13 |
| 08/01/2024 | Q2 | $2.4B | $2.5B | $4.00 | $4.03 | -$0.03 |
| 04/24/2024 | Q1 | $2.3B | $2.3B | $2.70 | $3.46 | -$0.76 |
| 02/13/2024 | Q4 | $2.5B | $2.4B | $1.71 | $3.18 | -$1.47 |
| 11/08/2023 | Q3 | -- | -- | -$0.47 | $3.98 | -$4.45 |
| 07/25/2023 | Q2 | -- | -- | $4.07 | $3.76 | $0.31 |
| 04/25/2023 | Q1 | -- | -- | $2.67 | $3.28 | -$0.61 |
| 02/15/2023 | Q4 | -- | -- | $3.79 | $3.48 | $0.31 |
| 10/25/2022 | Q3 | -- | -- | $7.84 | $4.13 | $3.71 |
| 07/20/2022 | Q2 | -- | -- | $7.24 | $4.07 | $3.17 |
| 05/03/2022 | Q1 | -- | -- | $2.06 | $4.36 | -$2.30 |
| 02/03/2022 | Q4 | -- | -- | $2.50 | $3.37 | -$0.87 |
| 10/20/2021 | Q3 | -- | -- | $2.22 | $4.07 | -$1.85 |
| 07/22/2021 | Q2 | -- | -- | $2.99 | $4.60 | -$1.61 |
| 04/22/2021 | Q1 | -- | -- | $2.69 | $4.94 | -$2.25 |
| 02/03/2021 | Q4 | -- | -- | $2.32 | $4.80 | -$2.48 |
| 10/21/2020 | Q3 | -- | -- | $4.46 | $8.05 | -$3.59 |
| 07/22/2020 | Q2 | -- | -- | $9.59 | $8.00 | $1.59 |
| 04/22/2020 | Q1 | -- | -- | $8.08 | $7.69 | $0.39 |
| 01/30/2020 | Q4 | -- | -- | $8.08 | $8.08 | $0.00 |
| 10/22/2019 | Q3 | -- | -- | $8.39 | $8.27 | $0.12 |
| 07/23/2019 | Q2 | -- | -- | -- | $7.53 | -- |
| 04/24/2019 | Q1 | -- | -- | -- | $6.96 | -- |
| 01/29/2019 | Q4 | -- | -- | -- | $6.72 | -- |
| 10/23/2018 | Q3 | -- | -- | -- | $6.76 | -- |
| 07/24/2018 | Q2 | -- | -- | -- | -- | -- |
| 04/24/2018 | Q1 | -- | -- | -- | -- | -- |
| 01/25/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/24/2017 | Q3 | -- | -- | -- | -- | -- |
| 07/25/2017 | Q2 | -- | -- | -- | -- | -- |
| 04/25/2017 | Q1 | -- | -- | -- | -- | -- |
| 01/26/2017 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2016 | Q3 | -- | -- | -- | -- | -- |
| 07/21/2016 | Q2 | -- | -- | -- | -- | -- |
| 04/21/2016 | Q1 | -- | -- | -- | -- | -- |
| 01/27/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/21/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/24/2015 | Q2 | -- | -- | -- | -- | -- |
| 04/24/2015 | Q1 | -- | -- | -- | -- | -- |
Biogen Earnings Questions
-
How Much did Biogen Generate in Revenue Last Quarter?
Biogen reported $2.5B worth of top line sales in its most recent quarter.
-
Did Biogen Beat Earnings Last Quarter?
Biogen announced earnings per share of $1.83 which represents a miss of analyst forecast a $3.36 per share.
-
Is Biogen Profitable?
Biogen reported $1.9B that represents $12.83 per share over the last quarter.
-
What is the Analyst Consensus for Biogen EPS Next Year?
Biogen's earnings are forecast to grow from $11.18 per share to $15.84 per share next year representing an increase of 41.68%.
-
When is Biogen's Earnings Date?
Biogen's next earnings date is April 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
